These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Wilson R; Aksamit T; Aliberti S; De Soyza A; Elborn JS; Goeminne P; Hill AT; Menendez R; Polverino E Respir Med; 2016 Aug; 117():179-89. PubMed ID: 27492530 [TBL] [Abstract][Full Text] [Related]
3. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Bilton D; Henig N; Morrissey B; Gotfried M Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030 [TBL] [Abstract][Full Text] [Related]
4. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis. Dhand R J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527 [TBL] [Abstract][Full Text] [Related]
5. [Chinese expert consensus on the management of lower respiratory tract infections of Pulmonary Infection Assembly of Chinese Thoracic Society Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044 [TBL] [Abstract][Full Text] [Related]
6. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis. Sangiovanni S; Morales EI; Fernández-Trujillo L Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314 [TBL] [Abstract][Full Text] [Related]
7. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection]. Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860 [TBL] [Abstract][Full Text] [Related]
8. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914 [TBL] [Abstract][Full Text] [Related]
9. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200 [TBL] [Abstract][Full Text] [Related]
11. Dual antibiotics for bronchiectasis. Felix LM; Grundy S; Milan SJ; Armstrong R; Harrison H; Lynes D; Spencer S Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012514. PubMed ID: 29889304 [TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumoniae and chronic endobronchial infections in childhood. Hare KM; Leach AJ; Smith-Vaughan HC; Chang AB; Grimwood K Pediatr Pulmonol; 2017 Dec; 52(12):1532-1545. PubMed ID: 28922566 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? King P Drugs; 2007; 67(7):965-74. PubMed ID: 17488142 [TBL] [Abstract][Full Text] [Related]